The -31C/G polymorphism (rs9904341) in the promoter of BIRC5 gene was genotyped by TaqMan MGB technology (Assay ID: C_25474467_10; Applied Biosystems, Foster City, CA, USA) according to the manufacturer's protocol.
Genotype data were obtained from a custom array using the Illumina Goldengate SNP technology assay platform.
PCT was measured with a time-resolved amplified cryptate emission technology assay (Kryptor PCT®; Brahms, Hennigsdorf, Germany).
Procalcitonin was measured with a time-resolved amplified cryptate emission technology assay.
For serum PCT measurement, we used a time-resolved amplified cryptate emission technology assay (Kryptor PCT, Brahms, Hennigsdorf, Germany).
PCT was measured in plasma with a time-resolved amplified cryptate emission technology assay (Kryptor PCT®; BRAHMS Aktiengesellschaft, Hennigsdorf, Germany).
All recent research has used the TRACE (time-resolved amplified cryptate emission) technology assay (Kryptor PCT; B·R·A·H·M·S Aktiengesellschaft, Henningsdorf, Germany).
PCT was measured with a TRACE (time-resolved amplified cryptate emission) technology assay (Kryptor PCT®; B·R·A·H·M·S Aktiengesellschaft, Hennigsdorf, Germany).
We measure ProCT by using a newly developed time-resolved amplified cryptate emission (TRACE) technology assay (Kryptor PCT, Brahms, Henningsdorf, Germany).
Urinary creatinine measurements were determined using the creatinine incorporating dynamic stabilization technology assay kits (Fisher Scientific) according to the standard procedure.
